How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Consumer Goods and Retail · Forecast 2027–2033
Calming Supplements For Pets Market
- By Product Type: Natural Herbal Supplements, CBD Oil and Treats, Amino Acid Supplements, Homeopathic Remedies, Vitamin and Mineral Blends
- By Pet Type: Dogs, Cats, Small Mammals (e.g., rabbits, guinea pigs), Birds
- By Formulation: Chewable Tablets, Soft Chews, Liquid Drops, Powder Mixes, Sprays
- By Distribution Channel: Veterinary Clinics, Pet Specialty Stores, Online Retailers, Mass Merchandisers
- By Active Ingredient: L-Theanine, Melatonin, Valerian Root, Chamomile Extract, Passionflower
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Natural Herbal Supplements leads By Product Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 14 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 298 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.182 →
- 12 Company Profiles 14 players: SWOT & benchmarking p.190 →
Full report · locked preview
Everything inside the Calming Supplements For Pets Market report
A complete, evidence-based study - 12 chapters and 125 sections covering market size, segmentation across 5 axes, regional analysis and 14 company profiles, forecast to 2033.
Segmentation covered
Product Type 5
Pet Type 4
Formulation 5
Distribution Channel 4
Active Ingredient 5
Companies profiled
Nestlé Purina PetCare
Mars Petcare
Bayer Animal Health
Zoetis
Virbac
Elanco Animal Health
Ceva Santé Animale
Ark Naturals
VetriScience Laboratories
NaturVet
Zesty Paws
Pet Naturals of Vermont
+2 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
14 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Nestlé Purina PetCare
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Mars Petcare
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Bayer Animal Health
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Zoetis
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Virbac
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Elanco Animal Health
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Ceva Santé Animale
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Ark Naturals
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →VetriScience Laboratories
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →NaturVet
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Zesty Paws
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Pet Naturals of Vermont
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.220 →Animal Essentials
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →King Bio
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$12,822M by 2033 · 11.0% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Natural Herbal Supplements60.2
- CBD Oil and Treats16.4
- Amino Acid Supplements7.7
- Homeopathic Remedies8.5
- Vitamin and Mineral Blends7.3
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$1,835M → $4,063M · 10.4%
Europe$1,279M → $3,117M · 11.8%
Asia Pacific$1,168M → $2,793M · 11.5%
Latin America$723.0M → $1,537M · 9.9%
Middle East and Africa$556.2M → $1,193M · 10.0%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →10.952026
10.962027
10.972028
11.002029
11.012030
11.022031
11.032032
11.042033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Nestlé Purina PetCare23.5
- Mars Petcare9.7
- Bayer Animal Health12.5
- Zoetis11.4
- Virbac4.3
- Elanco Animal Health10.7
- Others27.9
Segment contribution to growth (%)
Fig. 18 · p.39 →Product Type9.4%
Pet Type29.6%
Formulation31.2%
Distribution Channel9.2%
Active Ingredient20.7%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America32.0
- Europe24.5
- Asia Pacific22.0
- Latin America12.1
- Middle East and Africa9.4
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Nestlé Purina PetCare | 83 | 87 | 80 | 95 | 99 | 81 | 88 |
| Mars Petcare | 73 | 82 | 73 | 83 | 74 | 73 | 76 |
| Bayer Animal Health | 85 | 87 | 67 | 82 | 68 | 81 | 78 |
| Zoetis | 64 | 82 | 64 | 74 | 58 | 79 | 70 |
| Virbac | 71 | 58 | 62 | 65 | 75 | 73 | 67 |
| Elanco Animal Health | 50 | 61 | 70 | 65 | 46 | 52 | 57 |
| Ceva Santé Animale | 61 | 65 | 46 | 55 | 42 | 57 | 54 |
| Ark Naturals | 47 | 45 | 49 | 39 | 58 | 39 | 46 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Nestlé Purina PetCare
- Mars Petcare
- Bayer Animal Health
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Nestlé Purina PetCare | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| Mars Petcare | ◐ | ◐ | ◐ | ✓ | ✓ | ✓ |
| Bayer Animal Health | ◐ | ✓ | ◐ | ✓ | ✓ | ✓ |
| Zoetis | − | ◐ | ◐ | ◐ | − | ✓ |
| Virbac | ✓ | ◐ | − | − | ◐ | ✓ |
| Elanco Animal Health | ◐ | ◐ | ✓ | ◐ | − | − |
| Ceva Santé Animale | ◐ | − | ◐ | − | − | ◐ |
| Ark Naturals | ◐ | ◐ | − | − | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Nestlé Purina PetCare88
2Bayer Animal Health78
3Mars Petcare76
4Zoetis70
5Virbac67
6Elanco Animal Health57
7Ceva Santé Animale54
8Ark Naturals46
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Nestlé Purina PetCareBayer Animal Health
Challenger3
Strong scale, closing on the leaders.
Mars PetcareZoetisVirbac
Contender1
Focused players with pockets of strength.
Elanco Animal Health
Niche2
Specialists in a single segment or region.
Ceva Santé AnimaleArk Naturals
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Product Type in North America, then scale across Calming Supplements For Pets Market — a $300M beachhead inside a $5.63B market.
Beachhead (SOM)$300Mobtainable near-term
Serviceable (SAM)$2.14Breachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale5 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion90 fit
Natural Herbal Supplements
Best fit — highest urgency & budget in Product Type.
Economic buyer77 fit
CBD Oil and Treats
Strong fit — clear ROI and a fast path to value.
End user70 fit
Amino Acid Supplements
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Product Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Pet Type & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Formulation
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales44%
Partner / channel30%
Digital / self-serve19%
Marketplaces8%
Positioning & messaging
§GTM 2 · p.194 →For Product Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Calming Supplements For Pets Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified41%
Sales qualified22%
Evaluation14%
Closed-won8%
$10.6KCAC
$46KLTV
4.4:1LTV : CAC
< 5 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Calming Supplements For Pets Market is a durable-growth opportunity — $6.57B by 2033, compounding at 7.0%.
TAM · 2025$3.84Btoday
TAM · 2033$6.57Bforecast
CAGR7.0%2027–2033
Cumulative$45.9Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$6.57BTotal addressable market
SAM$2.28BServiceable available market
SOM$388MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →7.0% CAGR
Demand compounds through 2033, outpacing GDP across Product Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Product Type moving from early to mainstream — durable secular demand.
Consolidation upside
14+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$6.57BLarge & growingTAM by 2033 at 7.0% CAGR
$2.28BServiceable nowreachable with today’s model
$388MBeachhead winobtainable near-term share
14+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$5.13BBear4.5% CAGR
$6.57BBase7.0% CAGR
$8.41BBull9.2% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Pet Type optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Calming Supplements For Pets Market — a $6.54B market by 2033. Plan: grow share from 9.7% to 15.8%.
Market size · 2033$6.54Btotal addressable
Market CAGR9.0%2027–2033
Target share15.8%from 9.7% today
Revenue ambition$1.03Bby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 9.7% | 15.8% | Behind |
| Revenue | $594M | $1.03B | On track |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | Ahead |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | On track |
| Gross margin | 30.9% | 42.9% | On track |
| Customer retention | 84.5% | 93.4% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Product Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Pet Type capability
A defensible second engine — invest in Pet Type to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Product Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Pet Type
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $134M capacity & capability investment
- Greenlight bolt-on M&A in Pet Type
- Authorise North America expansion plan
- Fund R&D program for Product Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAhead
- Competitive share lossBehind
- Input-cost & supply riskAhead
- Regulatory / policy changeBehind
- Execution & talentAt risk
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Calming Supplements For Pets Market conversation — a $2.76B market you can size, segment and defend in minutes.
Market size · 2033$2.76Btotal opportunity
Growth5.1%CAGR to 2033
Addressable buyers1,190+accounts in scope
Typical ROI5.4×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Product Type
Goal Grow share in Product Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →5.4×return on cost, year one
< 3 mopayback period
$93K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
14+players profiled in this market
Coverage includes
Nestlé Purina PetCareMars PetcareBayer Animal HealthZoetisVirbacElanco Animal HealthCeva Santé AnimaleArk Naturals+6 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Calming Supplements For Pets Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Calming Supplements For Pets Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Consumer Goods and Retail · scroll →Calming Sheet Mask Market
Market size, share, segmentation and regional forecast.
$6.3B market · 2025 base year
View reportCalming Products for Pet Market
Market size, share, segmentation and regional forecast.
$1.1B market · 2025 base year
View reportCalming Pheromone Spray Market
Market size, share, segmentation and regional forecast.
$643M market · 2025 base year
View reportCalming Pheromone Diffuser Market
Market size, share, segmentation and regional forecast.
$4.5B market · 2025 base year
View reportCalming Chews for Dogs Market
Market size, share, segmentation and regional forecast.
$5.5B market · 2025 base year
View reportCalming Aids for Dogs Market
Market size, share, segmentation and regional forecast.
$1.9B market · 2025 base year
View reportSoft Drink Dispensers Market
Market size, share, segmentation and regional forecast.
$5.0B market · 2025 base year
View reportCalligraphy Pen Market
Market size, share, segmentation and regional forecast.
$2.7B market · 2025 base year
View reportHome Gym Exercise Equipment Market
Market size, share, segmentation and regional forecast.
$2.6B market · 2025 base year
View reportRetail Shelving Systems Market
Market size, share, segmentation and regional forecast.
$2.7B market · 2025 base year
View reportCalf Sleeve Market
Market size, share, segmentation and regional forecast.
$3.2B market · 2025 base year
View reportCommercial Frozen Beverage Machines Market
Market size, share, segmentation and regional forecast.
$2.5B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.